Connect with us
European Gaming Congress 2024

Artificial Intelligence

Carbapenem-Based Antibiotics Market Size Worth $5.34Bn, Globally, by 2028 at 4.4% CAGR – Exclusive Report by The Insight Partners

Published

on

New York, March 16, 2022 (GLOBE NEWSWIRE) — The Insight Partners published latest research study on “Carbapenem-Based Antibiotics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)”, the global carbapenem-based antibiotics market growth is driven by the rising prevalence of gram-negative bacterial infections, the increasing production of generics drugs, the significant growth in hospital-acquired bacterial infections and the rise in incidence of antimicrobial resistances increased the demand for broad spectrum antibiotics. However, the tedious and expensive process for the development of antibiotics hampers the growth of the market.

Get Exclusive Sample Pages of Carbapenem-Based Antibiotics Market Size – COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00027228/

Report Coverage Details
Market Size Value in US$ 3,964.57 Million in 2021
Market Size Value by US$ 5,346.62 Million by 2028
Growth rate CAGR of 4.4% from 2021 to 2028
Forecast Period 2021-2028
Base Year 2021
No. of Pages 180
No. Tables 84
No. of Charts & Figures 77
Historical data available Yes
Segments covered Type, Indication, and Distribution Channel
Regional scope North America; Europe; Asia Pacific; Latin America; MEA
Country scope US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Carbapenem-Based Antibiotics Market: Competitive Landscape and Key Developments
Companies operating in the carbapenem-based antibiotics market implement various organic developments that led to dynamic improvements in the market. Various organic growth strategies, such as product launch, product approval, and product development, enhance the market growth. Similarly, several companies are implementing inorganic numerous strategies, such as partnerships, collaborations, merger & acquisition.

Inquiry Before Buying: https://www.theinsightpartners.com/inquiry/TIPRE00027228/

In January 2022, Spero Therapeutics received Priority Review designation by the U.S. Food and Drug Administration (FDA) and confirmed the acceptance for substantive review of the New Drug Application (NDA) seeking approval for tebipenem HBr oral tablets for treatment in adult patients with complicated urinary tract infections (cUTI), including acute pyelonephritis, caused by susceptible microorganisms.

Advertisement
Stake.com

In October 2021, Spero Therapeutics announced the submission of New Drug Application to the Food and Drug Administration (FDA) for tebipenem HBr (tebipenem pivoxil hydrobromide) for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis, caused by susceptible microorganisms. The company further announced to work along with FDA during the NDA review process for tebipenem HBr’s anticipated launch in the second half of 2022.

In February 2022, Sumitomo Dainippon Pharma Co., Ltd entered in partnership with its parent company Sumitomo Dainippon Pharma Co., Ltd to launch phase 1 study in the US on a new drug candidate (“KSP-1007”) for carbapenem-resistant bacterial infections. The launch was a result of a joint research project between Sumitomo Dainippon Pharma and the Kitasato Institute in Japan.

Speak to Research Analyst: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00027228

In January 2021, Aurobindo Pharma Ltd announced that the central government has listed three companies along with Hyderabad based Aurobindo Pharma that qualified for financial support under the production linked incentive (PLI) scheme for the promotion of domestic manufacturing of critical key starting materials (KSMs), drug intermediates, and active pharmaceutical ingredients (APIs). Aurobindo Pharma Ltd made an investment of USD 407.394 million to set up production facilities for three eligible products.

Global Carbapenem-Based Antibiotics Market: Key Insights – Future Trend
Technological developments in the pharmaceutical industry led to drastic evolution and better treatment. The pharmaceutical industry has incorporated intelligent technologies such as deep learning, artificial intelligence (AI), and machine learning to develop new antibiotics. Researchers are working to establish tools and platforms for identifying new antibiotics. It is expected that the novel technologies in new antibiotic discoveries are supposed to change the overall antibiotics market. However, developing antibiotics for gram-negative bacteria is challenging, as various drugs are still developing.  

Advertisement
Stake.com

The major challenge during the antibiotic development is limited permeability of molecule across bacterial envelope. This has allowed researchers to develop a new platform called computational antibiotic screening (CLASP), which helps identify potential drug molecules through porins. CLASP has the advantage of coarse grain (CG) resolution, advanced sampling techniques, and a parallel computing environment that maximizes its performance. Thus, it is expected that CLASP will be enabled or accelerate the new antibiotic drug for gram-negative bacterial infections, thus further leading to significant market growth.

Buy Premium Copy of Carbapenem-Based Antibiotics Market Size, Share, Revenue, Strategic Insights and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00027228/

Carbapenem-Based Antibiotics Market: Segmental Overview
Based on type, the carbapenem-based antibiotics market is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest market share in 2021 and is expected to register the highest CAGR during the forecast period. The others segment consists of drugs such as Ertapenem, Vabomere, and Sulopenem (pending FDA approval) that falls under the carbapenem family. The drugs are used to treat various bacterial infections caused by gram negative bacteria. Many infections, such as includes cUTIs, bronchopulmonary infection, complicated intra-abdominal infections, Acute pelvic infections, lower respiratory tract infections, gynecologic infections, and pseudomonas infections, can be treated with carbapenem-based antibiotics treatment. The segment is expected to contribute significantly to the growth of the carbapenem-based antibiotics market due to constant developments in the pharmaceutical industry, increasing incidence of bacterial infections, and growing regulatory approvals for drugs.

Browse Adjoining Reports:
Carbapenem Market Forecast to 2028 – Covid-19 Impact and Global Analysis – by Type ( Meropenem, Doripenem, Imipenem Tebipenem, and Others ); Indication ( Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, and Others ); and Distribution Channel ( Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies )

Antibiotics and Antimycotics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type (Penicillins, Cephalosporins, Carbapenems, Macrolides, Aminoglycosides, Quinolones (Fluoroquinolones), Sulfonamides, Tetracyclines, Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Advertisement
Stake.com

Antibiotics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors), and Geography

Enterobacteriaceae Infection Drug Market Forecast to 2028 – Covid-19 Impact and Global Analysis – By Type (Beta-Lactams Drugs, Carbapenems Drugs, Fluoroquinolones Drugs, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Systemic Antibiotics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Drug Class (Penicillin, Tetracycline, Fluoroquinolones, Macrolides, Others); Indication (Urinary Tract Infections, Acne, Respiratory Tract Infections, Skin or Soft Tissue Infection, Dental Disorders, Diabetic Foot Infections, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Aminoglycoside Antibiotics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Others); Route of Administration (Parenteral, Oral, Others); Application (Urinary tract infection, Respiratory tract Infection, Skin Infections, Others) and Geography

IVD Infectious Diseases Market Forecast to 2028 – Covid-19 Impact and Global Analysis – By Product (Instruments, Reagents, Software); Technology (Immunochemistry, Microbiology, Molecular Diagnostics); Application (MRSA, Streptococcus, Clostridium, Vancomycin-resistant enterococci, Carbapenem-resistant Bacteria, Respiratory virus)

Advertisement
Stake.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/carbapenem-based-antibiotics-market

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Asia Mobiliti Applauded by Frost & Sullivan for Powering Intelligent Urban Mobility and Offering Customer Value with Its MaaS Solutions

Published

on

asia-mobiliti-applauded-by-frost-&-sullivan-for-powering-intelligent-urban-mobility-and-offering-customer-value-with-its-maas-solutions

Asia Mobiliti’s efficient, sustainable, and interconnected mobility solutions improve user experience, reduce congestion and environmental impact, and reshape urban spaces.
SAN ANTONIO, June 26, 2024 /PRNewswire/ — Frost & Sullivan recently researched the mobility-as-a-service (MaaS) industry and, based on its analysis, recognizes Asia Mobiliti with the 2024 Asia-Pacific (APAC) Customer Value Leadership Award. As a pioneering start-up, the company has dedicated itself to reshaping urban mobility by actively developing innovative data products. It specializes in designing, engineering, and operating a cutting-edge data platform aimed at powering intelligent urban mobility. The platform seamlessly connects fleet operators, transport providers, transit authorities, and end users through a data-driven approach. The company’s comprehensive suite of products and services include:

Internet of Things (IoT) and Machine Learning powered digital city solutionsMaaS technologiesDemand-Responsive Transit systemsMobility data servicesAsia Mobiliti’s unique mobility platform integrates IoT and telematics with journey planning, enabling it to lead transport digitalization. The company catalyzes innovative data-driven and artificial intelligence solutions for the transit and mobility ecosystem, facilitating the widespread adoption of MaaS across emerging markets. Asia Mobiliti is at the forefront of revolutionizing intelligent urban mobility, offering diverse products and services. The company’s connected vehicle systems provide real-time tracking and monitoring capabilities for vehicles and fleets. These systems have analytics tools that optimize routes, enhance fuel efficiency, and improve fleet performance. Asia Mobiliti places a significant emphasis on mobility data services, utilizing the power of data to offer valuable insights for informed decision-making processes. Over the long term, it envisions reducing congestion, reducing environmental impact, and reshaping urban spaces while replacing spaces traditionally reserved for parking and traffic with more sustainable, natural living spaces.
Ming Lih Chan, industry principal for Frost & Sullivan’s mobility practice, observed, “Asia Mobiliti disrupts the traditional transportation system model and promotes the development of public travel needs. Its MaaS integrates multiple transportation modes and combines private and public modes of transport with demand-responsive services, which sustainably meets the different needs of the public.”
Asia Mobiliti’s Trek Rides and Trek App solutions represent a paradigm shift in urban mobility. Trek Rides, an on-demand transit service, efficiently fills the first-mile/last-mile gaps by merging the convenience of ride-hailing with the dedicated supply of public transport. This reduces traffic congestion, lowers travel costs, and facilitates the shift towards net-zero emission goals. Trek’s MaaS engine employs advanced algorithms for comprehensive multimodal journey planning, ensuring the seamless integration of various transportation modes. Additionally, Trek API facilitates integration with 3rd-party systems and super apps. Asia Mobiliti’s unique selling proposition lies in its compelling price/performance value within the highly competitive mobility services landscape, granting it a distinctive competitive edge in effectively addressing a broad spectrum of client needs.
“Asia Mobiliti underlines its supremacy in the MaaS sector through its strategic commitment to collaboration and customization. The company is a pivotal partner for governments, transit authorities, and large clients, offering a user-friendly platform backed by cutting-edge technology. Asia Mobiliti earns recognition as the best-in-class provider in the dynamic MaaS landscape for its operational efficiency, consistent revenue growth, and forward-looking expansion strategy,” added Norazah Bachok, best practices research analyst at Frost & Sullivan. As a cost-effective and innovative market player, the company solidifies its position by delivering exceptional client value.
Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in implementing strategies that proactively create value for customers with a focus on improving the return on the investment that customers make in its services or products. The award recognizes the company’s unique focus on augmenting the value that its customers receive, beyond simply good customer service, leading to improved customer retention and customer base expansion.
Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact us: Start the discussion.
Contact:
Tarini SinghP: +91 9953764546E: [email protected] 
About Asia MobilitiFounded in 2018 and based in Kuala Lumpur, Malaysia, Asia Mobiliti is an award-winning, Malaysia Digital status company providing a Mobility-as-a-Service (MaaS) platform and digital city solutions designed and engineered for the developing world. We adopt a technology platform approach with a core software-defined engine that is capable of spawning innovative mobility solutions that encompass Internet of Things (IoT)-enabled advanced telematics, machine learning-based mobility-as-a-service technology, as well as a wide variety of transit technologies, such as demand-responsive transit, transport service analytics, condition monitoring for rail and road and account-based ticketing and payments.
For more information, visit asiamobiliti.com or email [email protected]
Photo – https://mma.prnewswire.com/media/2447280/Frost_and_Sullivan_2024_Asia_Mobiliti_Award_.jpg

View original content:https://www.prnewswire.co.uk/news-releases/asia-mobiliti-applauded-by-frost–sullivan-for-powering-intelligent-urban-mobility-and-offering-customer-value-with-its-maas-solutions-302182092.html

Continue Reading

Artificial Intelligence

More than 150,000 money laundering accounts detected in APAC

Published

on

more-than-150,000-money-laundering-accounts-detected-in-apac

Region sees 108% increase in voice scams as fraudsters continue shift to mobile
MELBOURNE, Australia and MUMBAI, India, June 25, 2024 /PRNewswire/ — A new financial crime report out today details how criminal organizations in the APAC region now outsource the laundering of money stolen via scams to international syndicates specializing in this cleaning. BioCatch identified and helped APAC banks shut down more than 150,000 money mule accounts in 2023 and estimates exponentially more such accounts in use across the region.

“Where there are scams, there are mules,” BioCatch Director of Global Fraud Intelligence Tom Peacock said. “Criminal organizations use these mule accounts as intermediate stops between the victim’s bank account and the final account from which they plan to withdraw their stolen money. The mules we’ve identified almost certainly represent a tiny fraction of those actively laundering money in the region, with more cropping up every day. Financial institutions in APAC and around the world must do more to identify these mules, hamper their ability to open new accounts, and identify those legitimate accounts money launderers succeed in turning from good to bad.”
In this latest edition of its Digital Banking Fraud Trends in APAC report, BioCatch – which identifies and prevents fraud and financial crime in real time by analyzing as many as 3,000 different physical behavior patterns (mouse movements and typing speed, for example) and cognitive signals (hesitation, segmented typing, etc.) in search of anomalies – points to mobile malware as the greatest threat to banks in Southeast Asia in 2024.
“Whether through SMS-mining or illegal loan apps, we’ve seen an explosion in Android-based malware in the region,” Peacock said. “Malware developers continue to innovate, circumventing bank and Google Play Store defenses to harvest what they need from mobile devices to access digital banking accounts and then transfer away the victim’s funds to a money mule.”
There is reason for hope in fighting fraud in APAC, however. In Australia, the number of reported scam cases grew by 13% in 2023, but scam losses declined by $90 million.
“Nine out of the 10 largest Australian banks employ BioCatch solutions to protect their customers from fraud and financial crime by analyzing the behavior of the user behind every online banking session,” BioCatch APAC Vice President Richard Booth said. “Already in 2024, we see massive progress: Money lost to fraud in the country declined by 48% in the first quarter of this year compared to Q1 of 2023. It’s difficult to reach any conclusion other than that BioCatch has left Australian digital-banking customers far safer from fraud than they were before.”
Other key findings:
No desktop or laptop needed: BioCatch found as much as 70% of all reported frauds in APAC originated from mobile apps in 2023, an increase of 17% from the year before.Scams are everywhere: Across the region, the number of reported voice scams increased by 108% in 2023.Australia bucking all trends: In addition to seeing fraud losses actually decline, the nation also saw fewer fraud cases involving malware or Remote Administration Tools (RATs) in 2023 than it did in 2022.Click here to access BioCatch’s complete 2024 Digital Banking Fraud Trends in APAC report.
About BioCatch:BioCatch stands at the forefront of digital fraud detection, pioneering behavioral biometric intelligence grounded in advanced cognitive science and machine learning. BioCatch analyzes thousands of user interactions to support a digital banking environment where identity, trust, and ease coexist. Today, more than 30 of the world’s largest 100 banks and 196 total financial institutions rely on BioCatch Connect™ to combat fraud, facilitate digital transformation, and grow customer relationships. BioCatch’s Client Innovation Board – an industry-led initiative featuring American Express, Barclays, Citi Ventures, HSBC, and National Australia Bank – collaborates to pioneer creative and innovative ways to leverage customer relationships for fraud prevention. With more than a decade of data analysis, 92 registered patents, and unmatched expertise, BioCatch continues to lead innovation to address future challenges. For more information, please visit www.biocatch.com.
Media contact:Jay [email protected]
Logo – https://mma.prnewswire.com/media/1843699/biocatch_logo_rgb_2x_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/more-than-150-000-money-laundering-accounts-detected-in-apac-302181474.html

Continue Reading

Artificial Intelligence

Puyi Fund, Managed by Highest Performances Holdings Inc., Surpasses RMB 24.0 Billion in Assets under Advice, Showing Promising Start to Strategic Transformation

Published

on

puyi-fund,-managed-by-highest-performances-holdings-inc,-surpasses-rmb-24.0-billion-in-assets-under-advice,-showing-promising-start-to-strategic-transformation

GUANGZHOU, China, June 25, 2024 /PRNewswire/ — Highest Performances Holdings Inc. (“HPH” or the Group, NASDAQ: HPH), announces that its Puyi Fund’s assets under advice for its asset allocation services reached RMB 24.7 billion as of June 21, 2024, reflecting a remarkable year-on-year growth of 188%. This substantial increase in scale showcases significant growth for the fund.

This accomplishment is primarily attributed to the Puyi Fund’s service philosophy, “long-term commitment to clients and clients’ long-term benefits,” introduced in 2023, as well as the ongoing efforts of the Company in adjusting its product strategy and embracing digital transformation. On one hand, the Company implemented a comprehensive family wealth management account system, redirecting its flagship products towards fixed-income funds and fund portfolios to enhance clients’ perception of wealth acquisition. On the other hand, the Company has elevated its overall service standard through digital transformation, greatly improving the client’s investment experience.
Transforming Product Strategy to Maximize Client Returns
In relation to product strategy transformation, Puyi Fund offers investors a comprehensive solution for managing their family wealth through a scientific approach. This solution guides investors in allocating their investment assets across three types of accounts: Flexible Withdrawal Accounts, Stable Appreciation Accounts, and High-Yield Pursuit Accounts. By considering various market conditions and cycles, investors can make informed decisions on how to distribute their funds among these accounts through a scientific approach for achieving risk mitigation, consistent asset growth, and long-term sustainable investment returns.
Taking into account the prevailing market conditions in China, Puyi Fund advises investors to allocate 25% to 90% of their funds to Stable Appreciation Accounts, depending on their risk tolerance. These accounts primarily involve investing in fixed-income funds, providing investors with consistent and reliable expected returns. By employing the stable appreciation strategy, Puyi Fund aims to restore investors’ confidence in the market, leading to increased trust and recognition. Consequently, Puyi Fund has experienced a period of rapid growth and positive development.
An analysis of data from the Chinese mutual fund market highlights the alignment of Puyi Fund’s client-centric product strategy transformation with market demands. According to Wind data, the market value of the Chinese mutual fund market stood at RMB 25.45 trillion at the end of 2021. By the end of May 2024, this amount grew to RMB 29.09 trillion, representing an increase of RMB 3.64 trillion or 14.30%. The value of equity and hybrid funds, however, experienced a decline from RMB 8.54 trillion to RMB 6.34 trillion, marking a decrease of RMB 2.21 trillion. In contrast, bond funds and money market funds collectively witnessed a significant increase of RMB 5.69 trillion. These market trends suggest that Chinese fund investors are shifting their risk preferences towards lower-risk and higher-certainty assets. Puyi Fund’s strategic transformation is well-positioned to take advantage of this evolving trend.
Enhancing Digital Service Innovation with a Focus on Client Service
In its digital transformation efforts, Puyi Fund places a strong emphasis on “client-centricity” and “service excellence”. By harnessing the power of big data, algorithm mining, and the Sensor Intelligent System, Puyi Fund establishes personalized service scenarios tailored to the unique needs of thousands of individuals. Through meticulous operations that cover the full client lifecycle, Puyi Fund offers full-scope online transactions for both public and private fund clients, establishing a distinctive digital competitive advantage. As of June 2024, the year-to-date client retention rate for fund advisory services stands at 75%, significantly enhancing the likelihood of investment profitability and returns for clients. This success enables clients to truly appreciate the value of advisory services and the time invested in their investments.
Furthermore, Puyi Fund has made continuous advancements in its intelligent client service system, leveraging digital platforms to offer investors comprehensive and efficient services. As of June 2024, the intelligent client service has catered to the needs of approximately 250,000 investors, providing 7*24 services, with a problem resolution rate surpassing 90%. Moreover, Puyi Fund complements intelligent client service with human support, resulting in a client satisfaction rate of 99%. This approach guarantees that investors receive timely and effective assistance whenever required.
Optimizing Trust-Based Communication Channels with Clients
Puyi Fund’s capability to swiftly establish client trust is attributable to its distinctive offline service channels. Unlike other third-party fund sales institutions that heavily rely on online platforms, Puyi Fund provides face-to-face, one-on-one services through offline channels. This approach is especially valuable in navigating complex investment environments, effectively calming investor emotions, enabling them to stay composed and gain a proper understanding of products, ultimately making well-informed investment decisions. Since 2024, Puyi Fund’s research and advisory team has released 28 specialized research reports and organized 19 online client exchanges, along with 35 offline client events, in response to market dynamics and client needs. These initiatives have effectively addressed investors’ concerns and enhanced their confidence.
It is worth mentioning that Puyi Fund’s institutional business has experienced remarkable growth this year, particularly in attracting clients from prominent financial institutions including banks, wealth management subsidiaries, and insurance companies. To cater specifically to institutional investors, Puyi Fund has developed an intelligent over-the-counter fund trading system called “Web-based Institution Master system”. This system provides institutional investors with a wide range of product portfolios, a comprehensive investment research system, and personalized trading experiences. As a result, it comprehensively improves the service quality and efficiency for institutional clients.
As of June 21, Puyi Fund established partnerships with 117 mutual fund companies, including the top 20 fund managers in terms of size, providing access to nearly 11,000 public funds and implementing over 20 customized advisory strategies. In the private fund sector, Puyi Fund has selected over 30 fund managers from the entire market. Of these, 38% manage assets over RMB 10 billion, while 29% manage assets between RMB 5 billion and RMB 10 billion. This selection covers a wide range of mainstream strategy products in the market, catering to the allocation needs of various types of investors.
It is reported that Puyi Fund, an independent third-party fund sales institution holding a fund sales business license issued by the China Securities Regulatory Commission, operates as a subsidiary of Highest Performances Holdings Inc. (NASDAQ: HPH). Embracing the concept of buyer advisor, Puyi Fund is dedicated to delivering comprehensive family financial asset allocation services to individual investors and diversified financial services to institutional investors through its financial technology service platform. With exceptional resource integration capabilities, professional research expertise, and high-quality client service, Puyi Fund strives to cultivate long-term partnerships with clients, catering to their personalized asset allocation needs in various scenarios while assisting a broader range of investors in achieving sustainable long-term returns. As of December 31, 2023, the accumulated assets under Puyi Fund’s allocation advisory services surpassed RMB 75.1 billion, exhibiting a compound annual growth rate of 128.8% from 2015 to 2023.
About Highest Performances Holdings Inc. (NASDAQ: HPH)
HPH was founded in 2010 with the aim of becoming a top provider of smart home and enterprise services. Its mission is to improve the quality of life for families worldwide, focusing on two main driving forces: “technological intelligence” and “capital investments.”HPH has a global strategic perspective and identifies high-quality enterprises with global potential for investment and operations. Its areas of focus include asset allocation, education and study tours, cultural tours, sports events, healthcare and elderly care and family governance.
HPH currently holds controlling interests in two leading financial service providers in China, namely Fanhua Inc., a technology-driven platform, and Fanhua Puyi Fund Distribution Co., Ltd., an independent wealth management service provider.
Highest Performances Holdings Inc., formerly known as Puyi Inc., was renamed on March 13, 2024 to reflect its strategic transformation.

View original content:https://www.prnewswire.co.uk/news-releases/puyi-fund-managed-by-highest-performances-holdings-inc-surpasses-rmb-24-0-billion-in-assets-under-advice-showing-promising-start-to-strategic-transformation-302181854.html

Continue Reading

Trending